The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease

View/ Open
Author
Mata, Ignacio F.
Hanna, David S.
Dorschner, Michael O.
Samii, Ali
Agarwal, Pinky
Roberts, John W.
Klepitskaya, Olga
Shprecher, David R.
Chung, Kathryn A.
Factor, Stewart A.
Espay, Alberto J.
Revilla, Fredy J.
Higgins, Donald S.
Litvan, Irene
Leverenz, James B.
Yearout, Dora
Inca-Martinez, Miguel
Martinez, Erica
Thompson, Tiffany R.
Cholerton, Brenna A.
Hu, Shu-Ching
Edwards, Karen L.
Zabetian, Cyrus P.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/s13024-015-0045-4Metadata
Show full item recordCitation
Mata, I. F., Y. Jang, C. Kim, D. S. Hanna, M. O. Dorschner, A. Samii, P. Agarwal, et al. 2015. “The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease.” Molecular Neurodegeneration 10 (1): 50. doi:10.1186/s13024-015-0045-4. http://dx.doi.org/10.1186/s13024-015-0045-4.Abstract
Objective: To identify the causal gene in a multi-incident U.S. kindred with Parkinson’s disease (PD). Methods: We characterized a family with a classical PD phenotype in which 7 individuals (5 males and 2 females) were affected with a mean age at onset of 46.1 years (range, 29-57 years). We performed whole exome sequencing on 4 affected and 1 unaffected family members. Sanger-sequencing was then used to verify and genotype all candidate variants in the remainder of the pedigree. Cultured cells transfected with wild-type or mutant constructs were used to characterize proteins of interest. Results: We identified a missense mutation (c.574G > A; p.G192R) in the RAB39B gene that closely segregated with disease and exhibited X-linked dominant inheritance with reduced penetrance in females. The mutation occurred in a highly conserved amino acid residue and was not observed among 87,725 X chromosomes in the Exome Aggregation Consortium dataset. Sequencing of the RAB39B coding region in 587 familial PD cases yielded two additional mutations (c.428C > G [p.A143G] and c.624_626delGAG [p.R209del]) that were predicted to be deleterious in silico but occurred in families that were not sufficiently informative to assess segregation with disease. Experiments in PC12 and SK-N-BE(2)C cells demonstrated that p.G192R resulted in mislocalization of the mutant protein, possibly by altering the structure of the hypervariable C-terminal domain which mediates intracellular targeting. Conclusions: Our findings implicate RAB39B, an essential regulator of vesicular-trafficking, in clinically typical PD. Further characterization of normal and aberrant RAB39B function might elucidate important mechanisms underlying neurodegeneration in PD and related disorders. Electronic supplementary material The online version of this article (doi:10.1186/s13024-015-0045-4) contains supplementary material, which is available to authorized users.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581468/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:22856934
Collections
- HMS Scholarly Articles [17875]
Contact administrator regarding this item (to report mistakes or request changes)